I am a breastfeeding mother and i want to know if it is safe to use Acido acetilsalicilico [Italian]? Is Acido acetilsalicilico [Italian] safe for nursing mother and child? Does Acido acetilsalicilico [Italian] extracts into breast milk? Does Acido acetilsalicilico [Italian] has any long term or short term side effects on infants? Can Acido acetilsalicilico [Italian] influence milk supply or can Acido acetilsalicilico [Italian] decrease milk supply in lactating mothers?
- DrLact safety Score for Acido acetilsalicilico [Italian] is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Acido acetilsalicilico [Italian] may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Acido acetilsalicilico [Italian] may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Acido acetilsalicilico [Italian] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Acido acetilsalicilico [Italian] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Excreted in non-significant amount into breast milk. Reye’s Syndrome has never been reported due to ASA through breast milk. It is thought to be highly unlikely to occur after isolated or small doses like those used for treatment of thrombosis or anti-abortion therapy. At high maternal dose, one case (dubious) of salicylic intoxication in the neonatal period and another case of thrombocytopenia in an infant have been reported. Likelihood of hemolysis should be considered in those patients with G6PD-deficiency. WHO Model List of Essential Medication: compatible while breastfeeding when used occasionally or small dose for antithrombotic prophylaxis management.
After Acido acetilsalicilico [Italian] ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal Acido acetilsalicilico [Italian] ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with Acido acetilsalicilico [Italian] administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, Acido acetilsalicilico [Italian] therapy. After daily low-dose Acido acetilsalicilico [Italian]g (75 to 325 mg daily), no Acido acetilsalicilico [Italian] is excreted into breastmilk and salicylate levels are low. Daily low-dose Acido acetilsalicilico [Italian] therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].
A 16-day-old breastfed infant developed metabolic acidosis with a salicylate serum level of 240 mg/L and salicylate metabolites in the urine. The mother was taking 3.9 g/day of Acido acetilsalicilico [Italian] for arthritis, and salicylate in breastmilk probably caused the infant's illness, but the possibility of direct administration to the infant could not be ruled out.[11] Thrombocytopenia, fever, anorexia and petechiae occurred in a 5-month-old breastfed infant 5 days after her mother started taking Acido acetilsalicilico [Italian] for fever. One week after recovery, the infant was given a single dose of Acido acetilsalicilico [Italian] 125 mg and the platelet count dropped once again. The original symptoms were probably caused by Acido acetilsalicilico [Italian] or salicylate in breastmilk.[12] Hemolysis after Acido acetilsalicilico [Italian] and phenacetin taken by the mother of a 23-day-old, glucose-6-phosphate dehydrogenase (G6PD) deficient infant was possibly due to Acido acetilsalicilico [Italian] in breastmilk.[13] In a telephone follow-up study, mothers reported no side effects among 15 infants exposed to Acido acetilsalicilico [Italian] (dosages and infant ages were unspecified) in breastmilk.[14]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.